Observational studyDiabetes, obesity & metabolism2026
SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials.
Pierre Bel Lassen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.